Artience Co., Ltd. has recorded a ¥9.197bn impairment loss in its consolidated results for the third quarter of the year to December 2026, tying it to two separate operating problems: a delayed battery-plant start-up at a major customer in Hungary and a deteriorating Turkish ink business.
Hungary: a customer's plant start is delayed
In an extraordinary report filed on 13 November 2026, the company said Europe's EV market is still expanding overall. In Hungary, however, a change of government was among the factors that delayed the start of operations at a major customer's battery plant.
Artience said it responded by revising its plans for the automotive lithium-ion battery materials business, including changes to its production and supply set-up.
That change in supply set-up left fixed assets idle at a manufacturing site in Japan. Artience booked an impairment loss on those assets. The attribution to the change of government is the company's own explanation.
Turkey: costs outran pricing
The second problem is a consolidated subsidiary in Turkey whose main business is manufacturing and selling liquid ink. Artience said hyperinflation continues in Turkey and that higher raw-material and energy costs linked to the situation in the Middle East were layered on top.
The subsidiary passed some costs through in its selling prices and cut costs by raising production efficiency, according to the report. Its operating result still worsened.
Artience said indications of impairment were identified in each of the two businesses, which led to the loss.
What the report leaves open
The extraordinary report gives one combined figure and does not split the ¥9.197bn between the battery-materials business, the idle Japanese assets and the Turkish subsidiary. It also does not describe the amount as a cash outflow; an impairment is an accounting write-down.
Artience filed the report under the disclosure rule for events with a significant effect on the group's financial position, results of operations or cash flows.